Leadership
GBM AGILE
REMAP-COVID
- About REMAP-COVID
- REMAP-COVID US Trial Sites
Ovarian CanceRx
News
Join Us
Contact
DONATE

GBM AGILE Opens to Paxalisib in Europe

MAY 31, 2022 | KAZIA THERAPEUTICS

https://www.kaziatherapeutics.com/site/PDF/0ad7a061-1457-45b0-841e-e84b9feeaf76/GBMAgileopenstopaxalisibinEurope

Copyright © 2022 Global Coalition for Adaptive Research. All Rights Reserved. 617-299-6471

The Global Coalition for Adaptive Research is registered as a 501(c)(3) nonprofit organization. Contributions to the Global Coalition for Adaptive Research are tax-deductible to the extent permitted by law.

Privacy • Design by Mintwich Creative • Development by Example 7

Home
Leadership
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE